In recent clinical trials in persons with obesity or overweight with associated conditions, tirzepatide decreased body weight and other cardiorenal risk factors (blood pressure, low-density lipoprotein cholesterol, glycated hemoglobin and albuminuria)
Semaglutide should not be used by people who have a history of pancreatitis
At 1 mg/mL, you would need 12.5 units, easy to read and draw
The dose is tailored to the patients needs, and monthly follow-ups ensure a shared, team-based approach to your wellness goals
Semaglutide is a GLP-1 receptor agonist that helps regulate blood sugar and appetite
But, she says, for people who struggle with obesity even after attempting to make healthy diet and lifestyle changes, semaglutide might be worth considering, as it can help a patient lose weight and prevent chronic diseases associated with obesity: When you're obese and you have additional chronic diseases associated with obesity, your risk of [further] chronic disease and death goes up markedly. According to Barnard, the potential downsides of semaglutide generally outweigh the benefits
